You are here

Petrusné Miltényi Zsófia

Petrusné Miltényi Zsófia

Petrusné Miltényi Zsófia
Name: Petrusné Miltényi Zsófia
Other profiles: Google Scholar
Profession: physician, haematologist

Publication list

Uploaded publications:
149
Publications in DEA:
144
OA:
37
Date range:
1998-2024
2024
  1. Méhes, G., Mokánszki, A., Ujfalusi, A., Hevessy, Z., Miltényi, Z., Gergely, L., Bedekovics, J.: Acute Erythroid Leukemia Post-Chemo-Radiotherapy and Autologous Stem Cell Transplantation Due to Multiple Myeloma: tracing the Paths to Leukemic Transformation.
    Int. J. Mol. Sci. 25 (14), 1-12, 2024.
    Journal metrics:
    Q2 Catalysis (2023)
    Q1 Computer Science Applications (2023)
    D1 Inorganic Chemistry (2023)
    Q1 Medicine (miscellaneous) (2023)
    Q2 Molecular Biology (2023)
    D1 Organic Chemistry (2023)
    Q1 Physical and Theoretical Chemistry (2023)
    D1 Spectroscopy (2023)
  2. Bedekovics, J., Madarász, K., Mokánszki, A., Deliné Molnár, S., Mester, Á., Miltényi, Z., Méhes, G.: Exploring p53 protein expression and its link to TP53 mutation in myelodysplasia-related malignancies - Interpretive challenges and potential field of applications.
    Histopathology. [Epub ahead of print]2024.
    Journal metrics:
    Q1 Histology (2023)
    Q1 Medicine (miscellaneous) (2023)
    D1 Pathology and Forensic Medicine (2023)
  3. Illés, Á., Dobó, B., Borics, F., Tóthfalusi, D., Pinczés, L., Miltényi, Z.: The Effect of Diagnostic and Therapeutic Changes on the Survival of Hodgkin's Lymphoma Patients (1980-2019).
    Medicina (Kaunas). 60 (8), 1-15, 2024.
    Journal metrics:
    Q2 Medicine (miscellaneous) (2023)
2023
  1. Illés, Á., Garai, I., Miltényi, Z.: Hodgkin-lymphomás betegek kezelésével szerzett tapasztalataink.
    Orv. hetil. 164 (11), 403-410, 2023.
    Journal metrics:
    Q4 Medicine (miscellaneous)
  2. Husi, K., Szabó, R., Pinczés, L., Földeák, D., Dudley, R., Szomor, Á., Koller, B., Gopcsa, L., Illés, Á., Miltényi, Z.: Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era: real-world data from Hungary.
    Ann. Hematol. 102 (9), 2555-2563, 2023.
    Journal metrics:
    Q2 Hematology
    Q1 Medicine (miscellaneous)
  3. László, I., Berhés, M., Tisza, K., Miltényi, Z., Balázsfalvi, N., Vaskó, A., Asztalos, L., Kertész, A., Fábián, Á., Kappelmayer, J., Fülesdi, B.: The prognostic value of laboratory parameters referring to hemopoietic stress in patients with COVID-19: a single center experience.
    Signa Vitae. 19 (3), 36-43, 2023.
    Journal metrics:
    Q3 Critical Care and Intensive Care Medicine
    Q3 Emergency Medicine
2022
  1. Husi, K., Pinczés, L., Fejes, Z., Nagy, B., Illés, Á., Miltényi, Z.: Combined prognostic role of TARC and interim 18F-FDG PET/CT in patients with Hodgkin lymphoma-real world observational study.
    Hell. J. Nucl. Med. 25 (2), 125-131, 2022.
    Journal metrics:
    Q3 Medicine (miscellaneous)
    Q3 Radiology, Nuclear Medicine and Imaging
2021
  1. Pinczés, L., Szabó, R., Miltényi, Z., Illés, Á.: The impact of autoimmune cytopenias on the clinical course and survival of Hodgkin lymphoma.
    Int. J. Hematol. 113 (2), 175-182, 2021.
    Journal metrics:
    Q2 Hematology
  2. Simon, Z., Virga, B., Pinczés, L., Méhes, G., Miltényi, Z., Barna, S., Szabó, R., Illés, Á.: Transition Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma- Our Histopathological and Clinical Experience With Patients With Intermediate Lymphoma.
    Pathol. Oncol. Res. 27 1-7, 2021.
    Journal metrics:
    Q3 Cancer Research
    Q2 Medicine (miscellaneous)
    Q3 Oncology
    Q2 Pathology and Forensic Medicine
2020
  1. Pinczés, L., Szabó, R., Illés, Á., Földeák, D., Piukovics, K., Szomor, Á., Gopcsa, L., Miltényi, Z.: Real-world efficacy of brentuximab vedotin plus bendamustine as a bridge to autologous hematopoietic stem cell transplantation in primary refractory or relapsed classical Hodgkin lymphoma.
    Ann. Hematol. 99 2385-2392, 2020.
    Journal metrics:
    Q2 Hematology
    Q1 Medicine (miscellaneous)
2019
  1. Méhes, G., Matolay, O., Beke, L., Czenke, M., Jóna, Á., Miltényi, Z., Illés, Á., Bedekovics, J.: Hypoxia related carbonic anhydrase IX expression is associated with unfavourable response to first-line therapy in classical Hodgkin's lymphoma.
    Histopathology. 74 (5), 699-708, 2019.
    Journal metrics:
    Q1 Histology
    Q1 Medicine (miscellaneous)
    Q1 Pathology and Forensic Medicine
  2. Matolay, O., Méhes, G., Beke, L., Czenke, M., Jóna, Á., Miltényi, Z., Illés, Á., Bedekovics, J.: Tracking the cluster of differentiation 30 and carbonic anhydrase IX enzyme expression pattern in classical Hodgkin lymphoma cases.
    In: 15th Warsaw International Medical Congress Abstract Book, The Students' Scientific Association of the Medical University of Warsaw, Varsó, 228-229, 2019. ISBN: 9788376374888
2018
  1. Kenyeres, A., Simon, Z., Batár, P., Gergely, L., Jóna, Á., Magyari, F., Miltényi, Z., Reményi, G., Szász, R., Váróczy, L., Barna, S., Garai, I., Illés, Á.: A PET-CT vizsgálatokkal szerzett tapasztalataink follicularis lymphomában.
    In: Malygnus Lymphoma Konferencia, Magyar Hematológiai és Transzfúziológiai Társaság, Debrecen, 53, 2018.
  2. Magyari, F., Ivánka, T., Simon, Z., Miltényi, Z., Kósa, K., Illés, Á.: Kognitív Diszfunkció a Hodgkin-lymphoma kezelése után.
    In: Malygnus Lymphoma Konferencia, Magyar Hematológiai és Transzfúziológiai Társaság, Debrecen, 63, 2018.
  3. Kárai, B., Miltényi, Z., Gergely, L., Széles, M., Kappelmayer, J., Hevessy, Z.: The impact of delayed sample handling and type of anticoagulant on the interpretation of dysplastic signs detected by flow cytometry.
    Biochem Med (Zagreb). 28 (2), 1-13, 2018.
    Journal metrics:
    Q2 Biochemistry (medical)
    Q2 Clinical Biochemistry
  4. Pinczés, L., Miltényi, Z., Illés, Á.: Young adults diagnosed with Hodgkin lymphoma are at risk of relapsing late: a comprehensive analysis of late relapse in Hodgkin lymphoma.
    J. Cancer Res. Clin. Oncol. 144 (5), 935-943, 2018.
    Journal metrics:
    Q2 Cancer Research
    Q1 Medicine (miscellaneous)
    Q2 Oncology
2017
  1. Kárai, B., Bedekovics, J., Miltényi, Z., Gergely, L., Szerafin, L., Ujfalusi, A., Kappelmayer, J., Hevessy, Z.: A single-tube flow cytometric procedure for enhancing the diagnosis and prognostic classification of patients with myelodysplastic syndromes.
    Int. J. Lab. Hematol. 39 (6), 577-584, 2017.
    Journal metrics:
    Q2 Biochemistry (medical)
    Q2 Clinical Biochemistry
    Q2 Hematology
    Q2 Medicine (miscellaneous)
Show all
updated: 2024-12-01, 01:45

SCImago quartiles of
scientific journal articles

Number of scientific articles: 103
Q1/D1 3 (2.9%)
Q1 17 (16.5%)
Q2 19 (18.4%)
Q3 20 (19.4%)
Q4 10 (9.7%)
N/A 37 (35.9%)
-
OK

SCImago subject areas and categories

Medicine (63)
Medicine (miscellaneous) (52)
Oncology (16)
Hematology (14)
Pathology and Forensic Medicine (9)
Biochemistry (medical) (2)
Histology (2)
Critical Care and Intensive Care Medicine (1)
Emergency Medicine (1)
Gastroenterology (1)
Immunology and Allergy (1)
Neurology (clinical) (1)
Pharmacology (medical) (1)
Public Health, Environmental and Occupational Health (1)
Radiology, Nuclear Medicine and Imaging (1)
Rheumatology (1)
Biochemistry, Genetics and Molecular Biology (17)
Cancer Research (12)
Biochemistry, Genetics and Molecular Biology (miscellaneous) (2)
Clinical Biochemistry (2)
Molecular Biology (1)
Agricultural and Biological Sciences (1)
Agricultural and Biological Sciences (miscellaneous) (1)
Chemical Engineering (1)
Catalysis (1)
Chemistry (1)
Inorganic Chemistry (1)
Organic Chemistry (1)
Physical and Theoretical Chemistry (1)
Spectroscopy (1)
Computer Science (1)
Computer Science Applications (1)
Immunology and Microbiology (1)
Immunology (1)
Neuroscience (1)
Neurology (1)
Pharmacology, Toxicology and Pharmaceutics (1)
Pharmacology (1)
Toxicology (1)

Genre chart

Year chart

Language chart

Journals

Show more

iDEa co-authors

Show more

Other co-authors

Show more
Balázsfalvi Norbert